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Abstract
Background: The tight junction is a dynamic structure that is regulated by a number of cellular
signaling processes. Occludin, claudin-1, claudin-2 and claudin-3 are integral membrane proteins
found in the tight junction of MDCK cells. These proteins are restricted to this region of the
membrane by a complex array of intracellular proteins which are tethered to the cytoskeleton.
Alteration of these tight junction protein complexes during pathological events leads to impaired
epithelial barrier function that perturbs water and electrolyte homeostasis. We examined MDCK
cell barrier function in response to challenge by the proinflammatory cytokines tumor necrosis
factor-α (TNFα) and interferon-γ (IFNγ).
Results: Exposure of MDCK cells to TNFα/IFNγ resulted in a marked sustained elevation of
transepithelial electrical resistance (TER) as well as elevated paracellular permeability. We
demonstrate that the combination of TNFα/IFNγ at doses used in this study do not significantly
induce MDCK cell apoptosis. We observed significant alterations in occludin, claudin-1 and claudin-
2 protein expression, junctional localization and substantial cytoskeletal reorganization.
Pharmacological inhibition of ERK1/2 and p38 signaling blocked the deleterious effects of the
proinflammatory cytokines on barrier function.
Conclusion: These data strongly suggest that downstream effectors of MAP kinase signaling
pathways mediate the TNFα/IFNγ-induced junctional reorganization that modulates MDCK cell
barrier function.
Background
Tight junction proteins combine to form an important
barrier which serves to limit paracellular transport in epi-
thelial cell lines [1]. Important studies have identified
occludin [2], junctional adhesion molecule (JAM) [3] and
the claudins [4] as tight junction proteins that restrict
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molecular movement within the paracellular space. These
tight junction proteins form a dynamic seal between epi-
thelial cells becoming the principle physical paracellular
barrier. The extracellular domains of adjacent occludin or
claudin molecules form interactions that restrict diffusion
[5]. The claudin family, with now more than twenty mem-
bers, has garnered much attention due to the heterogene-
ous expression patterns observed in a variety of epithelia
and endothelial cell types. Complex arrays of claudin spe-
cies with unique distribution patterns are found in each
segment of the kidney [6]; for instance the distal tubule
contained measurable expression of both claudin-3 and -
8. MDCK II cells express claudin-1, -2, -3 and -4 [7], the
expression of claudin-2 in the MDCK II cells is in part
responsible for its low electrical resistance profile [8].
The response of the kidney epithelium to inflammatory
mediators is complex; an early study demonstrated that
Tumor Necrosis Factor-α(TNFα) exposure impaired bar-
rier function [9]. The renal epithelium has been shown to
produce TNFα as well as other potent proinflammatory
cytokines in response to external stressors such as
ischemia-reperfusion injury [10,11]. TNFα mRNA levels
increased significantly thirty minutes after ischemia and
inhibition of TNFα bioactivity decreases neutrophil infil-
tration and preserves renal function [12]. Investigation of
the proximal tubule LLC-PK cell model shows that in
order to produce a compromised epithelium the TNFα
dose must elicit apoptosis [13,14]. The combination of
TNFα and Interferon-γ (IFNγ) exposure in model epithe-
lial cell lines such as Caco-2 cells [15,16] and T84 cells
[17,18] results in loss of TER and increased paracellular
permeability. Finally, in a recent MDCK cell study using a
model of chronic exposure to TNFα for five days, claudin-
1 expression eventually decreased and tight junctions
were disrupted [19].
Mitogen-activated protein (MAP) kinases a family of ser-
ine-threonine kinases, have a fundamentally important
roles as signal transducers. Activation of MAP kinases by
various growth factors and cytokines are important mole-
cules involved in modulating cellular responses [20,21].
In terms of tight junction regulation the role of MAP
kinase signaling has been of interest [22,23]. MAPK kinase
(MEK) overexpression led to epithelial dedifferentiation
in MDCK-C7 cells [24]. Tight junction biogenesis was
inhibited in MDCK cells expressing constitutively active
MAP kinase; pharmacological inhibition of MEK1 signal-
ing in these cells permitted tight junction formation [25].
Pharmacological inhibition of MEK, a Ras effector known
to phosphorylate extracellular signal-regulated kinase 1
and 2 (ERK1 and ERK2), attenuated dexamethasone-
induced tight junction formation in the Con8 mammary
tumor cell line [26]. In these studies, the mitogenic effect
of MAP kinase activity is logically opposed to tight junc-
tion formation. The analysis of the effects of external stim-
uli on tight junction regulation, specifically the activated
signaling pathways, will provide valuable insight into
tight junction regulation.
The goal of this present study was to characterize the
response of MDCK cells to the combination of TNFα/
IFNγ. We hypothesized that TNFα/IFNγ would impair
MDCK cell tight junction function. We examined TER,
paracellular flux, tight junction protein expression and
localization in response to the proinflammatory
cytokines. In a variety of disease states inflammation is
thought to negatively impact epithelial barrier function,
we report that TNFα/IFNγ co-administration to MDCK
cell monolayers impaired epithelial barrier function as
measured by elevated paracellular flux and produced
marked elevation in transepithelial electrical resistance
(TER). Occludin, claudin-1 and claudin-3 protein expres-
sion was induced by TNFα/IFNγ exposure, whereas clau-
din-2 levels decreased; tight junction protein localization
was modulated contributing to impaired tight junction
function. Inhibition of MEK1 and p38 signaling during
exposure to TNFα/IFNγ, abrogated these cytokine-
induced effects in MDCK cells.
Results
Effect of TNFα and IFNγ on cellular cytotoxicity
In order to determine whether TNFα/IFNγ induced cyto-
toxic effects in the MDCK cell cultures, we determined the
percentage of apoptotic cells in confluent MDCK cultures
using the TUNEL assay (Table 1) and measured LDH
enzyme activity (Figure 1A) released from treated conflu-
ent cultures. No significant differences were found in per-
Table 1: Determination of Apoptosis in MDCK Monolayers. Confluent MDCK cultures were placed in one of the indicated treatment 
groups for 24 hours. Cells were then fixed and apoptotic cells were label using the TUNEL technique. Fluorescent microscopy was 
used to analysze of total cell number by DAPI staining and apoptotic cells by fluorescein incorporation. The mean ± SE of TUNEL 
positive cells is reported from three independent experiments. ANOVA was performed followed by a Bonferroni post test with all 
comparisons against the cells in media containing 5% FBS and glucose, *P < 0.01.
G l u c o s e ++++-
S e r u m ,  5 % ++++-
IFNγ, ng/ml - 20 60 200 -
TNFα, ng/ml - 10 30 100 -
TUNEL Positive (%) 4.1 ± 0.7 4.3 ± 0.9 5.5 ± 1.3 5.9 ± 1.3 10.5 ± 1.3*BMC Physiology 2006, 6:2 http://www.biomedcentral.com/1472-6793/6/2
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cent of TUNEL positive cells following treatment for 24
hours with increasing doses of TNFα/IFNγ. As a positive
control, cells were serum and glucose starved for 24 hours,
and this resulted in a significant increase in TUNEL posi-
tive cells (Table 1). The LDH activity assay revealed that
exposing MDCK cell cultures to increasing doses of TNFα/
IFNγ for 24 hours produced an increase in LDH activity
(Figure 1A) that was significantly different from media
alone controls at the two highest doses 6.5* ± 2.0%, and
8.2* ± 0.3%. Examination of MDCK cultures by phase-
contrast microscopy indicates that even at the highest
experimental doses of TNFα/IFNγ, cell monolayers are
intact. Using an established model of apoptosis and
necrosis [27], MDCK cells were serum and glucose starved
for 21 hours followed by addition of antimycin A (10 µM)
for the final 3 hours to deplete ATP, this resulted in release
of LDH that was significantly greater than the highest
TNFα/IFNγ treatments (data not shown).
Depriving MDCK cells of serum and glucose for 24 hours
resulted in a significant increase in paracellular flux with a
corresponding decrease in transepithelial electrical resist-
ance (Table 2), when deprived cells were depleted of ATP,
flux increased dramatically while TER values declined to
levels near baseline. Interestingly, when serum and glu-
cose deprived cells were treated with TNFα/IFNγ (30/60
ng/ml) the TER values reversed and increased compared
to starvation alone. Collectively, these data support the
hypothesis that the combination of these cytokines alters
tight junction function independently from apoptotic or
necrotic mechanisms.
Effect of TNFα and IFNγ on transepithelial electrical 
resistance
Analysis of transepithelial electrical resistance (TER) in
MDCK cells provides a reliable method for estimation of
tight junction integrity. Confluent MDCK cell cultures
were exposed to either TNFα or IFNγ for 24 hours before
TER was measured. Exposure to TNFα induced a dose
dependent elevation in TER (Figure 2A), whereas expo-
sure to IFNγ induced no significant effect on MDCK cell
TER.
A time-course was performed for up to 72 hours on con-
fluent MDCK cell cultures exposed to TNFα/IFNγ while
TER was monitored at regular intervals. Figure 3A repre-
sents the changes in TER under the following conditions
media only control, TNFα/IFNγ, 3/6 ng/ml, TNFα/IFNγ,
10/20 ng/ml, and TNFα/IFNγ, 30/60 ng/ml. In the first six
hours of cytokine exposure TER values are relatively sta-
ble. Between 12 and 24 hours, a significant dose-depend-
ent elevation of TER is observed. MDCK cells have 70.3 ±
0.6 Ω*cm2 of resistance, at 24 hours cells treated with 3/6
ng/ml of TNFα/IFNγ developed 99.9 ± 0.8 Ω*cm2 and
115.7 ± 1.9 Ω*cm2 when treated with 30/60 ng/ml of
TNFα/IFNγ. This represents a 65% increase in TER at 24 hr
in the presence of the highest concentration of cytokine.
Interestingly, between 24 and 72 hours there is a return
toward baseline in MDCK cells treated with the lower
doses of cytokine, whereas cells treated with the highest
dose show a 104% increase in TER. These studies imply
that treatment with TNFα/IFNγ in MDCK cells positively
regulates factors that contribute to TER.
Effect of Inflammatory Cytokine Concentration on MDCK  Cell Barrier Function Figure 1
Effect of Inflammatory Cytokine Concentration on 
MDCK Cell Barrier Function. Lactate dehydrogenase 
release (Panel A) was measured in confluent MDCK cell cul-
tures 24 hours following exposure to increasing doses of 
TNFα and IFNγ. Results are expressed as percent of maximal 
LDH release determined by incubating MDCK cells with TX-
100 (2%) five minutes prior to LDH activity assay. The mean 
LDH is reported, error bars represent the SE, four inde-
pendent experiments were assayed in duplicate. Fluorescein 
flux (Panel B) was measured following 24 hour treatment 
with increasing dose of TNFα and IFNγ. Fluorescein (50 µM) 
was added to the apical chamber and recovery was measured 
from the basal chamber after a 120 minute incubation. The 
mean fluorescence is reported, error bars represent the SE 
of four independent experiments. A one-way analysis of vari-
ance (ANOVA) was performed, multiple comparisons 
between control and treatments were determined with the 
Bonferroni post test. **Indicates statistical difference (P < 
0.001) to control.
L
D
H
 
A
c
t
i
v
i
t
y
 
R
e
l
e
a
s
e
 
(
%
)
**
0%
5%
10%
15%
20%
25%
TNFα, ng/ml 0 100 30 10 3
IFNγ, ng/ml 0 200 60 20 6
**
TNFα, ng/ml
IFNγ, ng/ml
0
0
3
6
0
500
1000
1500
2000
2500
10
20
**
100
200
**
30
60
**
F
l
u
o
r
e
s
c
e
i
n
 
F
l
u
x
 
(
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
)
A.
B.BMC Physiology 2006, 6:2 http://www.biomedcentral.com/1472-6793/6/2
Page 4 of 15
(page number not for citation purposes)
To investigate the contribution of the MAP kinase signal-
ing pathway we employed several potent and specific
pharmacological agents. MDCK cell grown to confluence
on Transwell inserts were treated with TNFα/IFNγ (30/60
ng/ml) for 24 hr in the presence and absence of a panel of
inhibitors (Figure 4A), U0126 (1 and 10 µM), SB202190
(1 and 10 µM) and a SP600125 (1 µM). Treatment with
TNFα/IFNγ resulted in a 95% increase in TER compared to
control cells, the addition of U0126 to cells treated with
cytokine resulted in a significant dose dependent decrease
in TER (37% and 55%). However, the treatment with
SB202190, a p38 inhibitor produced a significant eleva-
tion of TER compared to cytokine alone, resulting in a
dose dependent increase of 33% and 80%. The combina-
tion of low doses of ERK1/2 and p38 inhibition in the
presence of cytokine produced minimal effect on the
cytokine-treated cells, due to their opposing action on
TER. The addition of SP600125, a JNK inhibitor did lower
TER values a modest 22% in the presence of cytokine.
MAP kinase activation and signaling pathways differen-
tially regulate TER in this model of cytokine exposure in
MDCK cells.
Proinflammatory cytokines elevate flux
The effect of flux assay temperature in confluent MDCK
cell cultures was determined, cells were placed into one of
two treatment groups for 24 hours; control or TNFα/IFNγ
(10 and 20 ng/ml). The paracellular flux tracer 4-kD FITC-
dextran (30 µM) was added to the apical chamber and
recovery was determined from the basolateral chamber at
given intervals. We observed a modest six percent increase
when the flux assay was performed at 37°C compared to
4°C using FITC-dextran. Additionally, exposure to TNFα/
IFNγ did not markedly alter transcellular permeability. We
observed an eight percent increase in FITC-dextran flux at
37°C when compared to the 4°C group. The modest
increase in FITC-dextran recovery due to elevated temper-
ature was expected, however, was not significantly differ-
ent from the 4°C treatment (data not shown).
In order to examine the effect of dose of TNFα/IFNγ on
epithelial barrier function confluent MDCK cultures were
treated for 24 hours then fluorescein flux was determined.
Fluorescein recovery was markedly elevated with increas-
ing dose of TNFα/IFNγ (Figure 1B). The lowest dose tested
resulted in a two-fold elevation in flux, doses of TNFα/
IFNγ (10/20, 30/60 and 100/200 ng/ml) produced a dose
dependent significant elevation in flux.
In Figure 2B, we report the [3H]-mannitol flux using
MDCK cultures treated for 24 hours with either TNFα or
IFNγ. [3H]-mannitol (2 µCi) was added to the apical
chamber and recovery was measured in the basolateral
chamber following a 120 minute incubation at 37°C. By
in large MDCK cell flux is resistant to effects of these
cytokines when administered alone, only the highest dose
of TNFα (100 ng/ml) produced a significant 40% eleva-
tion of paracellular flux compared to control. IFNγ alone
had no detectable effect on MDCK flux.
In Figure 3B, we report the [3H]-mannitol flux using
MDCK cultures treated for 72 hours with TNFα/IFNγ. In
control cells, approximately 2% of the [3H]-mannitol is
recovered in the basolateral chamber following a 120
minute assay. MDCK cells treated with TNFα/IFNγ (30/60
ng/ml) produce a two-fold increase in [3H]-mannitol flux
permitting 4% of the label to enter the basolateral com-
partment. In this model of inflammatory stress using
MDCK cells, TER and flux appear not to be inversely
related.
We investigated the effect of MAP kinase pathway inhibi-
tors on paracellular flux using MDCK cells exposed to
TNFα/IFNγ (30/60 ng/ml) for 24 hr. Following analysis of
TER, [3H]-mannitol flux assays were performed and
reported as percent of control (Figure 4B). TNFα/IFNγ
resulted in a 66% increase in flux compared to control
cells, U0126 significantly decreased flux (44 and 45%),
SB202190 decreased flux dose-dependently (30% and
64%), the combination of U0126 and SB202190 signifi-
Table 2: Effect of Media Composition on MDCK Barrier Function. Confluent MDCK cultures were placed in one of the indicated 
treatment groups for 24 hours. Antimycin A (10 µM) was added at 21 hours following onset of experiment. The mean TER and 
fluorescein flux ± SE is reported from four independent experiments. ANOVA was performed followed by a Bonferroni post test with 
all comparisons against the cells in media containing 5% FBS and glucose, *P < 0.01.
Glucose + - - + -
Serum, 5% + - - + -
IFNγ, ng/ml - - - 60 60
TNFα, ng/ml - - - 30 30
Antimycin A, 10 µM- - + - -
TER, Ω*cm2 72.3 ± 0.5 62.2 ± 2.5 7.1 ± 0.3* 162.2 ± 3.5* 105.0 ± 4.9*
Fluorescein Flux, AU 247.9 ± 8.5 1198.2 ± 52.1* 9201.7 ± 250.5* 2005.3 ± 50.5* 2440.3 ± 45.6*BMC Physiology 2006, 6:2 http://www.biomedcentral.com/1472-6793/6/2
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cantly lowered flux 60% back to control levels whereas
SP600125 did not significantly alter flux. In these experi-
ments, inhibition of ERK1/2 and/or p38 signaling during
TNFα/IFNγ exposure significantly protects MDCK cell bar-
rier function.
Western blot analysis of tight junction- related proteins
To examine the causative factors related to elevated para-
cellular flux and decreased TER, selected tight junction
gene products were examined by Western Blot. Occludin,
claudin-1, claudin-2 and claudin-3 expression were exam-
ined in MDCK cells in response to TNFα/IFNγ dose fol-
lowing a twenty-four hour exposure (Figure 5A). In
general, low dose of TNFα/IFNγ produces an initial eleva-
tion in tight junction protein expression with the excep-
tion of claudin-2; the intensity and patterns observed
vary. In Figure 5B, exposure to TNFα/IFNγ (3/6 ng/ml) for
twenty-four hours induced a significant 37% ± 6% eleva-
tion in claudin-1 expression when compared to control as
measured by densitometric analysis. The occludin expres-
sion pattern (Figure 5B) is comparable to claudin-1, how-
ever the magnitude of elevation is modest, only a 22% ±
6.5% was observed at the lowest TNFα/IFNγ dose. Clau-
din-2 levels decrease markedly in a dose-dependent man-
ner to 45% ± 7% of control values. Analysis of claudin-3
(Figure 5B) indicated a slightly different expression pat-
tern; we observed a modest but not significant increase
with all doses of TNFα/IFNγ tested.
In order to examine dynamic changes in protein expres-
sion a differential detergent extraction procedure was
employed using cytokine-treated MDCK cells. Represent-
ative immunoblots of occludin and claudin-1 are pre-
sented in Figure 6A. The densitometric ratio of TX100-
insoluble fraction to TX100-soluble fraction for occludin
and claudin-1 was reported in Figure 6B. TNFα/IFNγ (10/
20 ng/ml) exposure for 24 hours resulted in decreased
occludin and claudin-1 in the TX100-insoluble fraction.
MDCK cells pretreated with U0126 (1 µM) for 15 minutes
prior to addition of TNFα/IFNγ showed a significant ele-
vation of occludin and claudin-1 in the TX100-insoluble
fraction, this finding is consistent with the improved bar-
rier function in ERK inhibited-TNFα/IFNγ-treated MDCK
cells. These data suggest that early MAP kinase signaling
events following TNFα/IFNγ exposure lead to both physi-
cal and functional remodeling of key tight junction pro-
teins.
Tight junction localization studies
Occludin, claudin-1, claudin-2 and claudin-3 localization
was examined using indirect immunofluorescence in
MDCK cells cultured on coverslips. Cells were treated for
24 hours in the absence and presence of TNFα/IFNγ. In
this study, differences in expression and localization were
quantified by examining junctional fluorescent intensity
in a deconvoluted z-stack comparing the highest intensity
of staining to the adjacent intracellular location (J/I ratio).
Occludin expression is robust and localized discreetly to
the cell's periphery (Figure 7A). Examination of the effect
of TNFα/IFNγ dose demonstrates an elevated occludin sig-
nal with a substantial increase detected at the cell-cell con-
tact regions (Figure 7B). Analysis of occludin fluorescence
intensity at the junction demonstrates a significant 55%
increase in signal detected. Claudin-1 staining is more
dynamic than occludin but generally the signal is local-
Tumor Necrosis Factor-α Elevates Transepithelial Electrical  Resistance and Flux in MDCK cells Figure 2
Tumor Necrosis Factor-α Elevates Transepithelial 
Electrical Resistance and Flux in MDCK cells. MDCK 
cells were treated with increasing dose of TNFα or IFNγ for 
24 hours; TER and [3H]-mannitol flux were determined. 
Panel A reports the mean percent change in TER, TNFα pro-
duced a significant dose dependent elevation in TER whereas 
IFNγ had minimal effects on TER. At 24 hours post treatment 
[3H]-mannitol (2 µCi) was added to the apical chamber, cells 
were incubated at 37°C for two hours, recovery of tracer 
was measured in the basolateral chamber and expressed as 
fold change from the control group. Error bars represent the 
SEM, n = 3. A one-way analysis of variance (ANOVA) was 
performed, multiple comparisons between control and treat-
ments were determined with the Bonferroni post test. 
**Indicates statistical difference (P < 0.001) to TNFα group 
(3 ng/ml).
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ized to the periphery (Figure 7D). TNFα/IFNγ treatment
produces a marked elevation of claudin-1 cytoplasmic
staining; the addition of U0126 restores claudin-1 locali-
zation to the periphery (Figure 7E). Claudin-2 staining is
localized to the periphery (Figure 7G), the TNFα/IFNγ
exposure produced a significant decrease in junctional
intensity (Figure 7H), U0126 produced little restoration
of claudin-2 staining in the presence of TNFα/IFNγ. In
contrast, claudin-3 staining (Figure 7J-L) and J/I analysis
demonstrated that exposure to TNFα/IFNγ has minimal
effect on claudin-3 localization.
Actin stress fiber analysis
Actin staining was examined using Texas-Red phallodin in
MDCK cells following twenty-four hour exposure to the
given treatments (Figure 7J-L). In this study, perijunc-
tional actin staining was analyzed in z-sections that corre-
sponded to the apical region containing the most intense
staining of a tight junction marker. Perijunctional actin
staining increased by more than a factor of two in the
TNFα/IFNγ-treated group (Table 3). Actin staining was
similar to the control group when TNFα/IFNγ was deliv-
ered in the presence of U0126.
Discussion
Epithelial cell layers play a critical role by separating phys-
iologically distinct compartments within most major
organ systems. The loss of tight junction barrier function
by deleterious inflammatory mechanisms is an important
problem in renal physiology due to the contribution of
these structures to the maintenance of ionic and water bal-
ance. Acute renal failure related to ischemic episodes pro-
foundly impairs the renal epithelium. Following
ischemia-reperfusion injury, cytoskeletal disruption and
loss of epithelial cell polarity contribute to back-leak of
glomerular filtrate into the blood [28]. In a recent study
following kidney transplant, decreased ZO-1 staining was
reported in response to postischemic injury [29]. Impor-
tantly, leukocyte infiltration is likely to occur in chronic
renal conditions such as diabetes, hypertension, autoim-
mune disorders leading to production of proinflamma-
tory cytokines [30-32]. In this study, we employ an
important renal cell model, (MDCK cells) to examine the
effects of proinflammatory cytokines on barrier function.
Initially, we were interested in determining whether the
proinflammatory treatment regiment was altering MDCK
barrier function as a cytotoxic effect. TNFα is a known acti-
vator of NF-κB, a transcription factor that promotes sur-
vival; in a recent report NF-κB activity was inhibited by
exogenous expression of Smad7 resulting in elevated
apoptosis in MDCK cells [33]. However, it was recently
reported that TNFα (30 ng/ml) initiated caspase-8 cleaved
PARP that induced apoptosis in serum starved MDCK
cells [34]. In the present study, MDCK cells were treated in
media containing five percent FBS to minimize serum
withdrawal responses, we report that the combination of
cytokines used in this study did not significantly induce
apoptosis. At the highest doses (30/60 and 100/200 ng/
ml) of cytokine treatment there was a moderate elevation
in LDH release, however this was less than a ten percent
elevation in LDH levels compared to control. Impor-
tantly, we report that paracellular flux increased in a
graded fashion with increasing dose of TNFα/IFNγ. When
Tumor Necrosis Factor-α and Interferon-γ Synergize to Ele- vate Flux in MDCK cells Figure 3
Tumor Necrosis Factor-α and Interferon-γ Synergize 
to Elevate Flux in MDCK cells. MDCK cells were treated 
with increasing dose of TNFα/IFNγ for up to 72 hours; TER 
and [3H]-mannitol flux were determined. Panel A reports the 
mean TER when cells were exposed to the following condi-
tions; media only control ( ), TNFα/IFNγ, 3/6 ng/ml ( ), 
TNFα/IFNγ, 10/20 ng/ml ( ), and TNFα/IFNγ, 30/60 ng/ml 
( ). Panel B reports the mean [3H]-mannitol flux following 
72 hour incubation with the indicated treatments. Flux is 
presented as the percent of apical [3H]-mannitol recovered 
in the basolateral chamber following 120 min. incubation. 
Error bars represent the SE, n = 6. A one-way analysis of var-
iance (ANOVA) was performed, multiple comparisons 
between control and treatments were determined with the 
Bonferroni post test. **Indicates statistical difference (P < 
0.001) to control.
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renal epithelial cells are exposed to agents that produce
necrosis and apoptosis investigators report a decrease in
TER along with a subsequent increase in paracellular flux
[27,35], we confirmed this finding in the MDCK system
by using a combination of energy starvation and ATP
depletion. We find that exposure of MDCK cells to TNFα/
IFNγ results in a decrease in ionic permeability which is
reported as increased TER values, in fact when MDCK cells
are serum and energy starved ionic permeability decreased
in response to TNFα/IFNγ. These data suggest that the
MDCK cell response to TNFα/IFNγ is distinct from a cyto-
toxic insult. In support of this concept a recent study using
the intestinal epithelial T84 cell line demonstrated that
the combination of TNFα/IFNγ increases paracellular per-
meability in an apoptosis-independent manner [36].
Therefore, although it is feasible to induce cell death in
MDCK cells by serum starvation and/or high doses of
TNFα for an extended duration, we are confident that the
perturbations reported in barrier function were conducted
using conditions that would activate NF-κB minimizing
induction of apoptotic events. These conditions appear to
result in a reorganization of the MDCK cell junctions with
minimal loss of junctional proteins.
In the present study we have demonstrated that pharma-
cological inhibition of MEK1 and p38 signaling in proin-
flammatory cytokine stimulated MDCK cells functionally
protects the barrier function. Several studies indicate that
MEK1 signaling increases paracellular permeability, there
exists some disparity in observed cellular responses.
Recently, a report demonstrated that inhibition of MEK1
signaling did not influence expression of occludin or clau-
din-1 or affect tight junction function in several breast
cancer cell lines [37]. Also, a study using enteropathogenic
Escherichia coli, showed that ERK1/2 was activated in T84
cells, but did induce tight junction barrier disruption as
measured by TER [38]. However, activation of MEK1 sig-
naling by H2O2 exposure in endothelial cells increased
permeability and resulted in occludin disorganization
[39]. Similar effects were also observed in Caco-1 and
MDCK cell lines [40]. In this present study, activation of
the ERK1/2 pathway by TNFα/IFNγ treatment produced
altered ionic permeability and dynamic changes in junc-
tional protein expression and localization. Additionally,
we found that TNFα alone potently decreased MDCK cell
ionic permeability while having only minimal impact on
paracellular flux. This suggests that the observed junc-
tional responses occur independent of apoptotic or
necrotic mechanisms that likely elevate paracellular flux.
Decreased ionic permeability in response to TNFα or
TNFα/IFNγ exposure coupled to the increased paracellular
flux of non-charged solutes when cytokines were pre-
sented in combination is intriguing. We find that inhibi-
tion of ERK1/2 signaling increased ionic permeability
toward control levels as expected but inhibition of p38
signaling further decreased ionic permeability levels
above cytokine treatment alone. This suggests that activa-
tion of the p38 pathway is antagonizing ERK1/2-mediated
effects on elevated TER in TNFα/IFNγ-treated MDCK cells.
While the MAP kinase inhibitors produced divergent
effects on cellular ionic permeability measurements both
inhibitors protected against increase paracellular flux of
Effect of MAP Kinase Inhibition on TER and Paracellular Flux  in TNFα and IFNγ-treated MDCK cells Figure 4
Effect of MAP Kinase Inhibition on TER and Paracel-
lular Flux in TNFα and IFNγ-treated MDCK cells. The 
effect of the MAP kinase inhibitors was investigated by TER 
assessment and [3H]-mannitol flux determination in the pres-
ence of TNFα and IFNγ. MDCK cells were placed into one of 
eight treatment groups for 24 hours; control, TNFα/IFNγ 
alone (30/60 ng/ml) or proinflammatory cytokine with U0126 
(1 and 10 µM), SB202190 (1 and 10 µM), combined U0126 
and SB202190 (1 µM each) or SB600125 (1 µM). TER was 
assessed using the EVOM system (Panel A) then flux was 
determined following incubation at 37°C for two hours with 
[3H]-mannitol in the apical chamber (Panel B). Recovery of 
tracer was measured in the basolateral chamber and 
expressed as fold change from the control group. Exposure 
to TNFα/IFNγ produces a significant two-fold elevation in 
paracellular flux; MAP kinase inhibitors protect barrier func-
tion to varying degrees. Error bars represent the mean ± SE 
of four independent experiments. ANOVA was performed, 
multiple comparisons between all treatments were deter-
mined with the Tukey-HSD post test. **Indicates statistically 
difference (P < 0.01) to the TNFα/IFNγ group.
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Effect of Proinflammatory Cytokine Concentration on MDCK Cell Tight Junction Proteins Figure 5
Effect of Proinflammatory Cytokine Concentration on MDCK Cell Tight Junction Proteins. Representative immu-
noblots of occludin, claudin-1, claudin-2 and claudin-3 total protein from confluent MDCK cell cultures twenty-four hours fol-
lowing exposure to increasing doses of TNFα and IFNγ (Panel A). Immunoblots were subjected to densitometric analysis; 
results are reported as percent of control to examine the effect of proinflammatory cytokines on tight junction protein expres-
sion (Panel B). Dashed horizontal lines represent control level of expression (100%), error bars represent the mean ± SE of 
eight independent experiments. ANOVA was performed, multiple comparisons between control and treatments were deter-
mined with the Bonferroni post test. **Indicates statistically difference (P < 0.01) to control.
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non-charged solutes. Several recent reports reveal that
ERK1/2 activation in MDCK II cells results in increased
TER. For instance, a recent study of cyclosporine A treated
MDCK cells produced elevated TER through a MAPK path-
way [41]. In another study of MDCK II cells, EGF receptor
activation resulted in increased TER with a concomitant
decrease in claudin-2 expression [7]. In a recent study of
MDCK II cells investigators demonstrate that these cells
have endogenously low ERK1/2 activity that corresponds
to high expression of claudin-2 [42]. ERK1/2 inhibition in
all of these studies prevented elevation of TER in the
MDCK II cell line. Recently investigators have determined
that claudin-2 forms cation-selective channels in the tight
junction complex [43,44], alteration in claudin-2 expres-
sion results in perturbations in ionic permeability. Con-
sistent with these studies we find a dose-dependent
decrease in claudin-2 expression in MDCK cells treated
with TNFα/IFNγ, this loss of claudin-2 correlates to a sub-
stantial reduction in ionic permeability. Elevation in TER
was inhibited by treatment with the ERK1/2 inhibitor but
not by inhibiting the p38 signaling pathway. These find-
ings are consistent with the current literature demonstrat-
ing that claudin-2 levels are regulated following ERK1/2
activation in MDCK cells and its expression level will
influence recorded TER from MDCK cultures.
The cellular tight junction response to proinflammatory
cytokines is variable based on cell type and numerous
physiological variables. Measurable changes in tight junc-
tion protein expression or localization that are predicted
to play a key role in maintaining barrier function are typ-
ically more unpredictable. We report a statistically signifi-
cant elevation in the protein expression of claudin-1, but
not occludin or claudin-3, following exposure to TNFα/
IFNγ. However, occludin protein levels are slightly ele-
vated in response to several doses of TNFα/IFNγ tested
compared to control. In this study, we report a dose-
dependent decrease in claudin-2 expression following
exposure to TNFα/IFNγ. The heterogeneous response of
tight junctional proteins to cytokine exposure may be due
to junctional remodeling which may involve additional
protein synthesis and altered turnover rates. In other stud-
ies, researchers have reported decreases, increases or no
change in tight protein expression following challenge
with proinflammatory mediator. For instance: TNFα
increased permeability while decreasing ZO-1 expression
through increased NFκB signaling, in a study using Caco-
2 cells [45]. Investigators report increased paracellular flux
with a decrease in TER following TNFα/IFNγ exposure
using a mouse cholangiocyte model; interestingly major
structural changes to the tight junction proteins (occludin,
claudin-1, -3, and ZO-1) were not detected [46]. Finally,
using T84 cells investigators find that inhibition of MEK
signaling impairs both basal and cytokine-induced tight
junction formation demonstrating an increased claudin-1
and claudin-2 protein expression in response to the
cytokine IL-17 [47]. Although it might be tractable to pre-
dict that exposure to proinflammatory cytokines would be
correlated to decreased expression of tight junction pro-
teins, our study is in agreement with other studies, finding
moderate effects on expression.
In the present study's examination of tight junction pro-
tein localization, treatment with ERK1/2 inhibitor in the
presence of TNFα/IFNγ enhanced occludin and claudin-1
expression at the junctional interface but did not signifi-
cantly affect claudin-2 or claudin-3. In the TNFα/IFNγ
treatment group there appears to be increased cytoplasmic
staining, possibly related to a lack of tethering related to
cytoskeletal rearrangements. Functionally, MDCK cells
pretreated with the ERK1/2 inhibitor exhibited no change
in flux or TER compared to control cells even in the pres-
ence of TNFα/IFNγ. Analysis of tight junction protein lev-
els demonstrated that pretreatment with U0126 in the
presence of TNFα/IFNγ induces protein levels similar to
control however, when the ERK1/2 inhibitor was added
two hours following treatment with TNFα/IFNγ, we
observed a similar magnitude of elevation in their expres-
sion, similar to TNFα/IFNγ alone. This suggests that early
events in the cytokine response are activated and produce
lasting effects on MDCK cells.
The actin cytoskeleton maintains an intimate association
with tight junctions through scaffolding proteins like ZO-
1, a member of the MAGUK family [48,49]. A recent study
using a glomerular epithelial cell model exposed to TNFα
for twenty-four hours reports an approximate two-fold
elevation in total actin content as determined by a DNase
I inhibition assay [50]. This finding is consistent with our
results based on perijunctional actin staining in MDCK
cells. We report a two-fold elevation of F-actin staining
following exposure to TNFα/IFNγ. This increase was pre-
vented by inhibition of ERK1/2 activation. It is also note-
worthy that other researchers have identified functional
relationship between MEK activation and cytoskeletal
organization. MEK-dependent pathway leads to cytoskel-
eton disruption in Ras-transformed fibroblasts [51]. Addi-
tionally studies examining epithelial dedifferentiation
show a loss of actin stress fibers [24,52]. MDCK cells stim-
ulated with HGF/SF produced actin cytoskeleton reorgan-
ization through the activation of MAP kinase, resulting in
junctional rearrangement [53]. Constitutively active Raf-1
in a salivary epithelial cell model induced actin reorgani-
zation and disrupted tight junctions by downregulation of
occludin [54]. The association between the cytoskeleton
and the tight junction suggests a structural and functional
relationship that provides a tractable model for under-
standing the regulation of barrier function.BMC Physiology 2006, 6:2 http://www.biomedcentral.com/1472-6793/6/2
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Conclusion
We demonstrated that MDCK tight junctions are func-
tionally reorganized in response to TNFα/IFNγ exposure
through the activation of ERK1/2. We find the junction
tightens by elevating the expression of occludin and clau-
din-1 in response to TNFα/IFNγ. Additionally, decreased
ionic permeability arises primarily through a significant
loss of claudin-2 expression due to ERK1/2 activation.
Apoptotic and necrotic mechanisms in response to TNFα/
IFNγ may contribute in part to the elevated paracellular
flux. Based on immunofluorescent findings, occludin and
claudin-1 localization appear to be in transition perhaps
due to the reorganization of the actin cytoskeleton. Acti-
vated ERK1/2 and p38 signaling pathways appear to be
responsible in part for both the curative and disruptive
patterns observed in this study.
Methods
Materials
Minimum Essential Medium Eagle (Mediatech, Herndon,
VA), L-glutamine, sodium pyruvate, non-essential amino
acids, fetal bovine serum (FBS), penicillin (200 U/mL),
streptomycin (200 µg/mL), trypsin/(0.03%) solution and
Transwell Systems were purchased from Fisher Scientific.
Human recombinant TNFα was purchased from Becton-
Dickinson (San Jose, CA). Human recombinant IFNγ was
purchased from R&D Systems (Minneapolis, MN).
U0126, SB202190 and SP600125 inhibitors were pur-
chased from EMD Biosciences (San Diego, CA). Polyclo-
nal rabbit anti-occludin, anti-claudin-1, anti-claudin-3
and monoclonal mouse anti-claudin-2 and antibodies
were purchased from Zymed Laboratories (South San
Francisco, CA). Horseradish Peroxidase (HRP) anti-rabbit
IgG, HRP-anti-mouse IgG2b and Texas Red anti-mouse
IgG2b antibodies were purchased from Jackson Immu-
noResearch Laboratories, Inc. (West Grove, PA). Alexa488
anti-rabbit IgG antibody and Texas Red Phallodin were
purchased from Molecular Probes (Eugene, OR). A cyto-
toxicity kit was supplied by Roche Applied Science (Indi-
anapolis, IN). D-[2-3H]mannitol was purchased from
Perkin Elmer (Wellesley, MA) and 4 KDa FITC-dextran
from Sigma Chemical (St. Louis, MO). All other reagents
were of the highest quality available.
Cell culture
MDCK cells (CCL-34) were obtained from ATCC (Manas-
sas, VA). MDCK cells were grown in Minimum Essential
Medium Eagle supplemented with L-glutamine (2 mM),
sodium pyruvate (1 mM), non-essential amino acids (0.1
mM), 5% FBS, penicillin (200 U/mL), streptomycin (200
µg/mL) in a humidified incubator at 37°C and 5% CO2.
MDCK cells are passaged using a trypsin (0.25%), EDTA
(0.03%) solution and culture dishes are reseeded follow-
ing a 1:4 dilution. Laboratory grade water (Millipore) is
used for all solutions and the water is routinely tested for
the presence of endotoxin using the Limulus Amebocyte
Lysate Assay (Sigma, St. Louis, MO).
Cytotoxicity measurement
Lactate dehydrogenase (LDH) activity released into the
supernatant of MDCK cell cultures was used as a measure
of cytotoxicity, manufacturer's instructions were followed.
Briefly, MDCK cells were grown to confluency in 24-well
plates then placed into one of the following five treatment
groups: control, or media containing TNFα and IFNγ with
the indicated concentrations; 3 and 6 ng/ml, 10 and 20
ng/ml, 30 and 60 ng/ml or 100 and 200 ng/ml respec-
ERK1/2 Inhibition Reverses Cytokine-induced Alterations in  Tight Junction Protein Distribution Figure 6
ERK1/2 Inhibition Reverses Cytokine-induced Altera-
tions in Tight Junction Protein Distribution. Repre-
sentative immunoblots of occludin and claudin-1 using Triton 
X-100 soluble and insoluble (SDS) fractions from confluent 
MDCK cell cultures treated for 24 hours in the indicated 
conditions (Panel A). The effect of the MEK inhibitor (U0126, 
1 µM) was added fifteen minute prior to addition of proin-
flammatory cytokines. Densitometic analyses were per-
formed, occludin (filled bars) and claudin-1 (open bars), ratio 
of SDS to TX-100 intensity was reported. Error bars repre-
sent the mean ± SE of four independent experiments. 
ANOVA was performed, multiple comparisons between all 
treatments were determined with the Tukey-HSD post test. 
**Indicates statistically difference (P < 0.05) to the control 
group, ***indicates a significant difference to the TNFα/IFNγ 
group (P < 0.05).
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Aberrant Localization of Tight Junction Proteins and Cytoskeletal Reorganization induced by Proinflammatory Cytokines in  MDCK Cells Figure 7
Aberrant Localization of Tight Junction Proteins and Cytoskeletal Reorganization induced by Proinflamma-
tory Cytokines in MDCK Cells. Immunofluorescence microscopy was used to capture digital images of MDCK cells grown 
to confluency on glass coverslips. Images A, D, G, J and M show control occludin, claudin-1, claudin-2, claudin-3 and actin stain-
ing respectively. Images B, E, H, K and N demonstrate occludin, claudin-1, claudin-2, claudin-3 and actin staining following 
twenty-four treatment with TNFα/IFNγ (10 and 20 ng/ml). Cells were treated TNFα/IFNγ for a 24 hour interval in the pres-
ence the ERK1/2 inhibitor U0126, 1 µM, representative images C, F, I, L and O were stained for occludin, claudin-1, claudin-2, 
claudin-3 and actin respectively. All images were captured on a Nikon 2000E microscope using a 60X oil-immersion lens, the 
calibration bar represents 25 µm.
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tively. MDCK cells were treated for 20 hours in complete
DMEM media and then placed in DMEM media contain-
ing 0.5% FBS without phenol red for the remaining 4
hours prior to assay. Cell culture plates were centrifuged
for 5 min at 1000 g and 100 µl of supernatant was trans-
ferred to an optically clear flat-bottom 96-well microtiter
plate. LDH activity assay was initiated by addition of 100
µl substrate and absorbance was measured at 492 nm
using a SpectraMax250 Platereader (Molecular Devices).
DMEM containing 0.5% FBS without phenol red was used
as assay medium to determine low control. Additionally,
a group of cells was lysed with 2% Triton-X100 ten min-
utes prior to supernatant collection to determine total cel-
lular LDH activity.
Apoptosis was detected using the DeadEnd™ Fluorometric
TUNEL System (Promega, Madison, WI). MDCK cells
grown to confluency on tissue culture treated coverglasses
were placed in a variety of conditions for 24 hours. Cells
were then fixed with paraformaldehyde (4%) in PBS for
25 minutes then permeabilized in PBS containg 0.2% Tri-
tion X-100 for 5 minutes. DNA fragments were labeled
with fluorescein-UTP using a recombinant terminal deox-
ynucleotidyl transferase for 1 hour at 37°C. Following six
wash steps in 2× SSC and PBS, nuclei were stained with
DAPI. Slides were stored in the dark at 4°C prior to micro-
scopic analysis using a Nikon 2000E microscope.
Transepithelial electrical resistance
MDCK cells are seeded on Transwell inserts and grown to
confluency. Experiments are preformed on cultures after a
minimum of ten days culture. In all experiments,
cytokines and inhibitors were delivered to both the apical
and basolateral chambers. Measurements of transepithe-
lial electrical resistance (TER) were made using an EVOM
epithelial voltohmmeter with an EndOhm 12 mm meas-
urement chamber calibrated daily using CaliCell™ (World
Precision Instruments, Sarasota, FL). Transwell inserts are
transferred to the measurement chamber containing
media (2 ml); the apical electrode is positioned prior to
obtaining measurement. Readings taken at time 0 hrs
were obtained immediately following addition of drug
treatments. The resistance of the epithelium was deter-
mined by passing a bipolar current across the epithelium
and measuring the resultant voltage change. The resist-
ance of the fluid and insert only between the voltage
measuring electrodes was measured and subtracted from
the total resistance. The transepithelial resistance was
automatically determined using Ohm's law.
Paracellular flux assay
MDCK cell monolayers in Transwell inserts were incu-
bated under different experimental conditions in the pres-
ence of 0.2 µCi/ml of D-[2-3H]-mannitol (15 Ci/mmol)
or sodium fluorescein (50 µM) in the apical well. At given
times, apical (30 µl) and basal (90 µl) media was with-
drawn and radioactivity was counted with a scintillation
counter. The flux into the basal well was calculated as the
percentage of total isotope administered into the basal
well per hour per cm2 of surface area. At 120 minutes fol-
lowing fluorescein addition, basal media (90 µl) was
placed in a Corning 96-well black assay plate and fluores-
cein was determined using a Typhoon Trio Plus (GE
Healthcare, Piscataway, NJ).
Table 3: Fluorescence Analyses of Junction Proteins and the Actin Cytoskeleton. Fluorescence intensity measurements were made 
using the line tool in MetaMorph Image Analysis software at the cell junction. The ratio of junctional to intracellular fluorescent is 
reported and the fluorescent intensity at the cell junctions are reported ± SEM. Actin staining was quantified at apical z-section stacks 
that corresponded to the same plane as the tight junction. Fluorescent intensity (arbitrary units) at the cell junction is reported in the 
lower panel. ANOVA was performed followed by a Bonferroni post test with all comparisons against the control group. A minimum of 
50 junctions were analyzed in each group *P < 0.001.
Fluorescence Intensity Ratio (Junctional/Intracellular)
Tight Junction Protein Control TNFα/IFNγ (10 and 20 ng/ml) TNFα/IFNγ with U0126 (1 µM)
Occludin 29.12 ± 1.79 *16.24 ± 0.78 *21.42 ± 1.15
Claudin-1 29.70 ± 2.79 *11.65 ± 1.53 *22.08 ± 1.51
Claudin-2 29.97 ± 1.76 *24.57 ± 1.98 *21.35 ± 1.73
Claudin-3 7.27 ± 0.57 7.11 ± 0.71 9.45 ± 0.88
Fluorescence Intensity (Junctional)
Actin 91.55 ± 5.2 *191.34 ± 10.6 116.5 ± 5.0
Occludin 644.7 ± 25.8 *917.6 ± 28.4 *1238.1 ± 30.2
Claudin-1 668.3 ± 27.6 *469.3 ± 22.9 557.4 ± 21.7
Claudin-2 545.4 ± 24.3 *364.0 ± 12.7 *357.4 ± 19.3
Claudin-3 204.8 ± 18.2 212.7 ± 18.3 250.0 ± 18.7BMC Physiology 2006, 6:2 http://www.biomedcentral.com/1472-6793/6/2
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Western blot analysis
Western blot analyses are processed using the following
protocol. Briefly, to prepare total cellular protein MDCK
cells are washed with cold PBS and lysed in buffer con-
taining 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS, 2 mM EDTA, 0.15 M NaCl, 0.01 M NaPO4, mini-
Complete protease inhibitor (Roche Applied Science)
with the following phosphatase inhibitors: 2 mM Na3VO4
and 10 mM NaF. DNA is sheared using a small gauge nee-
dle, and insoluble material is precipitated by centrifuga-
tion. Supernatants were collected and stored at -20°C for
analyses.
The method to prepare Triton X-100-soluble and -insolu-
ble fractions was adapted from Singh et. al. [7] with minor
modifications. MDCK cells were scraped into lysis buffer
(10 mM HEPES, pH 7.2, 1% Triton X-100, 100 mM NaCl,
2 mM EDTA and protease inhibitors) and incubated for
20 min. at 4°C. Following centrifugation, supernatants
were collected and considered the TX-100 soluble frac-
tions, the pellets were placed in lysis buffer containing 1%
SDS and TX-100 insoluble proteins were released by three
sonication pulses (40% duty cycle at output control level
4) using a Branson Sonifier 450. Insoluble material was
removed by centrifugation, supernatants were collected
and stored at -20°C for analyses.
Protein concentration was determined using the Pierce
BCA (Rockford, IL) microtiter plate protocol using albu-
min as a reference standard. Lysates are denatured at 95°C
for 5 min in Lammeli sample buffer, electrophoresed on
10% SDS-PAGE gels, and electroblotted to PVDF mem-
brane for immunodetection. Tight junction specific antis-
era including anti-occludin and claudin-1 and -3 were
employed in this study. Immunoblots are processed by
blocking non-specific binding sites in 5% non-fat milk in
Tris buffered saline with 0.1% Tween 20 (TBS-T) for 30
minutes followed by incubation with diluted primary
antibody (1/5000) for 2 hours at room temperature.
Immunoblots are then washed three times in TBS-T fol-
lowed by incubation with an HRP-conjugated secondary
antibody (1/10,000). Following extensive washing with
TBS-T, immunoblots are developed with a stable West
Pico chemiluminescent substrate (Pierce, Rockford, IL).
The image was captured on the VersaDoc 3000 and ana-
lyzed with the integrated QuantityOne 1-D analysis soft-
ware.
Immunofluorescent analysis
MDCK cell monolayers were grown on culture-treated
cover slips and treated for 24 hours in one of the follow-
ing conditions: media only, TNFα/IFNγ (10/20 ng/ml), or
TNFα/IFNγ with U0126 (1 µM, 15 min. pretreatment).
Layers were rinsed once with sterile PBS and placed on ice
for ten minutes. Cells were permeabilized with an actin
stabilizing permeabilization buffer containing 0.2% Tri-
ton-X100, 100 mM KCl, 3 mM MgCl2, 1.3 mM CaCl2, 25
mM sucrose, and 2 mM HEPES, pH 7.1 for 2 min on ice.
Cells were then fixed with cold 95% ethanol in PBS for 30
min on ice, rinsed once with PBS and blocked with 1%
BSA in PBS for 10 min followed by incubation for 1 hour
with tight junction protein-specific primary antibodies in
a moist environment at 25°C. Cells were rinsed three
times with PBS and incubated with Alexa488-conjugated
antibodies for 45 min. Primary and secondary antibodies
were diluted into 0.2% BSA in PBS and spun at 10,000 ×
g for 15 min at 4°C before incubation. Rhodamine-phal-
loidin (50 ng/ml) staining was performed after three PBS
washes for 20 min. Following extensive rinse steps, cover-
slips are coated with anti-fade medium and stored in the
dark at 4°C prior to microscopic analysis using a Nikon
2000E microscope fitted with a z-stepper motor and Met-
aMorph Image Analysis Software. Fluorescent intensity
was measured from a minimum of 50 cell junctions per
slide, data from a minimum of three independent experi-
ments were pooled for analysis.
Statistics
Multiple comparisons were made using one-way analysis
of variance (ANOVA) followed by either the Bonferroni
when comparing multiple samples to control or Tukey
HSD post-hoc test. A p value < 0.05 was considered signif-
icant.
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